Stock ROQ ROQUEFORT THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Roquefort Therapeutics plc

Equities

ROQ

GB00BMDQ2T15

Investment Management & Fund Operators

Delayed London S.E.
Other stock markets
 05:40:37 2024-04-29 am EDT 		5-day change 1st Jan Change
4.525 GBX -0.55% Intraday chart for Roquefort Therapeutics plc -4.74% -37.59%
Apr. 26 EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany AN
Apr. 26 Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Reports FY23 Loss GBX-1.35 MT

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 7.55 8.556
Enterprise Value (EV) 1 6.65 6.233
P/E ratio -3.77 x -4.24 x
Yield - -
Capitalization / Revenue 11,852 x -
EV / Revenue 10,439 x -
EV / EBITDA - -
EV / FCF - 5,428,748 x
FCF Yield - 0%
Price to Book 1.85 x 1.19 x
Nbr of stocks (in thousands) 71,900 129,150
Reference price 2 0.1050 0.0662
Announcement Date 5/11/22 6/4/23
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022
Net sales 1 0.000637 -
EBITDA - -
EBIT 1 -0.383 -1.634
Operating Margin -60,121.98% -
Earnings before Tax (EBT) 1 -0.6881 -1.634
Net income 1 -0.6881 -1.615
Net margin -108,018.05% -
EPS 2 -0.0279 -0.0156
Free Cash Flow - 1.148
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 5/11/22 6/4/23
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022
Net Debt 1 - -
Net Cash position 1 0.9 2.32
Leverage (Debt/EBITDA) - -
Free Cash Flow - 1.15
ROE (net income / shareholders' equity) - -28.6%
ROA (Net income/ Total Assets) - -16.6%
Assets 1 - 9.749
Book Value Per Share 2 0.0600 0.0600
Cash Flow per Share 2 0.0100 0.0200
Capex - -
Capex / Sales - -
Announcement Date 5/11/22 6/4/23
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Investment Management & Fund Operators

1st Jan change Capi.
ROQUEFORT THERAPEUTICS PLC Stock Roquefort Therapeutics plc
-37.59% 7.32M
BLACKROCK, INC. Stock BlackRock, Inc.
-6.03% 113B
UBS GROUP AG Stock UBS Group AG
-3.91% 87.91B
APOLLO GLOBAL MANAGEMENT, INC. Stock Apollo Global Management, Inc.
+20.42% 63.85B
BROOKFIELD CORPORATION Stock Brookfield Corporation
+5.29% 61.9B
BANK OF NEW YORK MELLON CORPORATION (THE) Stock Bank of New York Mellon Corporation (The)
+10.12% 42.86B
AMERIPRISE FINANCIAL, INC. Stock Ameriprise Financial, Inc.
+7.95% 40.84B
3I GROUP PLC Stock 3i Group plc
+19.13% 34.58B
T. ROWE PRICE GROUP INC. Stock T. Rowe Price Group Inc.
+5.88% 25.46B
STATE STREET CORPORATION Stock State Street Corporation
-5.25% 22.13B
Other Investment Management & Fund Operators
  1. Stock Market
  2. Equities
  3. ROQ Stock
  4. Financials Roquefort Therapeutics plc